cisatracurium 2 MG/ML Injectable Solution

RxCUI: 199211
RxNorm name: cisatracurium 2 MG/ML Injectable Solution
Display name: cisatracurium 2 MG/ML Injectable Solution
Full name: cisatracurium 2 MG/ML Injectable Solution
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Hospira, Inc.	67908e20-044d-454d-9c51-bf106e817bd0	2026-05-25	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Camber Pharmaceuticals Inc.	d8b5eb77-b393-4cd7-86c5-d2a9d131f96d	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Somerset Therapeutics, LLC	23daa1f8-2a07-449d-97a6-11efdb0b9836	2026-04-29	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Eugia US LLC	2cb05c7e-6228-4e2d-a270-7659e3db3fa7	2025-11-07	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Hikma Pharmaceuticals USA Inc.	46c815f6-7a3d-43a3-b470-3377b126ba09	2025-05-15	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium besylate	CISATRACURIUM BESYLATE	Gland Pharma Limited	0bacc37a-5e7f-4f05-9206-56fc8041c1ad	2025-04-04	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium	CISATRACURIUM BESYLATE	Fresenius Kabi USA, LLC	f78a07e2-0d3b-4460-b29e-8c10c90afbda	2025-02-21	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium besylate	CISATRACURIUM BESYLATE	Caplin Steriles Limited	93101770-10a1-4bad-a762-289c793d8ace	2025-01-17	Warnings, Adverse reactions	Exact identifier rxcui: 199211
cisatracurium besylate	CISATRACURIUM BESYLATE	Sandoz Inc	2ee0358e-2cce-40d3-9fcf-1b9088815c98	2024-10-31	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium besylate	CISATRACURIUM BESYLATE	Slate Run Pharmaceuticals, LLC	e06c4d57-bfc7-45ad-b1cd-b5b88dc43b50	2024-03-25	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Meitheal Pharmaceuticals Inc.	1be30efe-4beb-411a-bf82-6e4ea68fd262	2023-06-05	Warnings, Adverse reactions	Exact identifier rxcui: 199211
Cisatracurium Besylate	CISATRACURIUM BESYLATE	Meitheal Pharmaceuticals Inc.	7c8c41b6-d07c-4740-84b7-603289104c59	2023-01-19	Warnings, Adverse reactions	Exact identifier rxcui: 199211

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 12 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
67908e20-044d-454d-9c51-bf106e817bd0	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	15	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20260525
23daa1f8-2a07-449d-97a6-11efdb0b9836	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	10	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20260429
f78a07e2-0d3b-4460-b29e-8c10c90afbda	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	9	These highlights do not include all the information needed to use Cisatracurium Besylate Injection safely and effectively. See full prescribing information for Cisatracurium Besylate Injection. Cisatracurium Besylate Injection, for intravenous use Initial U.S. Approval: 1995	20250221
2cb05c7e-6228-4e2d-a270-7659e3db3fa7	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	6	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20251107
2ee0358e-2cce-40d3-9fcf-1b9088815c98	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	6	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20241031
7c8c41b6-d07c-4740-84b7-603289104c59	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	6	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20230119
46c815f6-7a3d-43a3-b470-3377b126ba09	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	5	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION . CISATRACURIUM BESYLATE injection for intravenous use Initial U.S. Approval: 1995	20250515
0bacc37a-5e7f-4f05-9206-56fc8041c1ad	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	4	These highlights do not include all the information needed to useCISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20250404
d8b5eb77-b393-4cd7-86c5-d2a9d131f96d	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	2	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection for intravenous use. Initial U.S. Approval: 1995	20260430
93101770-10a1-4bad-a762-289c793d8ace	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	2	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE Injection, for intravenous use Initial U.S. Approval: 1995	20250117
e06c4d57-bfc7-45ad-b1cd-b5b88dc43b50	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	2	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20240325
1be30efe-4beb-411a-bf82-6e4ea68fd262	cisatracurium 2 MG/ML Injectable Solution [PSN] · cisatracurium 2 MG/ML Injectable Solution [SCD] · cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution [SY]	3	1	These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995	20230605